Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer
ClinicalTrials.gov study NCT02770014. IPD Sharing: NO. Countries: 1. Publications: 0.
TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Di
ClinicalTrials.gov study NCT02322281. IPD Sharing: Not stated. Countries: 10. Publications: 0.
NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer
ClinicalTrials.gov study NCT00856375. IPD Sharing: Not stated. Countries: 6. Publications: 0.
A Phase 1b/2 Study of Safety and Efficacy of Rociletinib in Combination With MPDL3280A in Patients With Advanced or Metastatic EGFR-mutant NSCLC
ClinicalTrials.gov study NCT02630186. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade Gliomas
ClinicalTrials.gov study NCT03134131. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib
ClinicalTrials.gov study NCT02155465. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLC
ClinicalTrials.gov study NCT03256136. IPD Sharing: NO. Countries: 1. Publications: 0.
Temsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IV
ClinicalTrials.gov study NCT01166126. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
ClinicalTrials.gov study NCT04148898. IPD Sharing: NO. Countries: 0. Publications: 10.
Study of CDX-3379, a Human Monoclonal Antibody Targeting ERBB3, in Combination With the MEK Inhibitor, Trametinib, in Patients With Advanced Stage NRAS Mutant and BRAF/NRAS Wildtype (WT) Melanoma
ClinicalTrials.gov study NCT03580382. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01719380. IPD Sharing: YES. Countries: 12. Publications: 0.
Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases
ClinicalTrials.gov study NCT03430947. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma
ClinicalTrials.gov study NCT05484622. IPD Sharing: YES. Countries: 1. Publications: 0.
Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04853043. IPD Sharing: NO. Countries: 1. Publications: 0.
A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
ClinicalTrials.gov study NCT04317599. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
ClinicalTrials.gov study NCT03412383. IPD Sharing: NO. Countries: 1. Publications: 1.
INCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors.
ClinicalTrials.gov study NCT03272464. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors
ClinicalTrials.gov study NCT05071183. IPD Sharing: Not stated. Countries: 1. Publications: 0.
APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT03745716. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02321540. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.